Project Grant R01CA294004
Award Date
9/1/24
Completion Date
7/31/29
Dollars Obligated
$696K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
The National Cancer Institute awarded a $684,333 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to The Trustees of Columbia University in the City of New York. The project, titled "Integrating Breast Cancer and Cardiovascular Disease Risk to Explore Decision-Making for Chemoprevention Among Racially/Ethnically Diverse Women at High Risk for Breast Cancer," aims to evaluate if patient and provider decision support that juxtaposes breast cancer...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...
The National Cancer Institute (NCI) awarded a $328,822 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Implenomics Llcs, a minority-owned, women-owned small business located in Marblehead, Massachusetts. The grant, effective September 20, 2024 through August 31, 2026, will fund the development and pilot testing of the Integrated Cancer Awareness Network (ICAN), an innovative mHealth platform. ICAN will provide cancer risk, symptom, and screening education to...
The National Cancer Institute (NCI) awarded a $432,304 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The Trustees of Columbia University in the City of New York, Health Sciences Division. The grant, awarded on January 3, 2025, supports a 5-year research project focused on "Enhanced Cancer Risk Predictions in Underrepresented Populations through Robust Multi-Source Data Integration." The project aims to develop novel data integration methods to...
This Project Grant award of $621,732 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to evaluate a proactive identification and digital mental health intervention approach to address the unmet psychosocial needs of individuals living with likely incurable cancer. The key products or services to be delivered through this 5-year grant include: 1) Comprehensively assessing the effectiveness of a proactive identification method paired with...
This federal Project Grant award for $194,778 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports the optimization of strategies to improve NCI-sponsored clinical trial participation across the Weill Cornell Medicine - Meyer Cancer Center sphere, which serves a diverse population of approximately 6 million patients in the New York City metropolitan area. The principal investigator, Dr. Tagawa, has extensive experience leading and mentoring others on NCI clinical...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support a $1,338,648 hybrid effectiveness-implementation trial of the CARES intervention at the University of Pittsburgh. CARES is an integrated electronic health record-based screening and stepped collaborative care program designed to improve patient-centered outcomes for over 18 million Americans living with cancer who experience clinically significant levels of depression,...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $218,886 to The Trustees of Columbia University in the City of New York to develop a new light-activated technology for targeted protein degradation in cancer cells. The project aims to optimize a photocatalytic system that can selectively degrade cancer proteins, such as the immune checkpoint receptor PD-1 and the oncogenic phosphatase SHP2, using deep red light to initiate targeted...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $193,144 to The Trustees of Columbia University in the City of New York to support a multidisciplinary postdoctoral training program focused on gastrointestinal (GI) cancers. The 5-year program, running from September 1, 2024 to August 31, 2029, aims to train the next generation of GI cancer researchers across basic science, translational, clinical, epidemiological, and...
This Project Grant award, identified as R25CA291554, was provided by the National Cancer Institute (NCI), part of the National Institutes of Health, under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award's objective is to test a comprehensive national accelerator program called INCITE (Increasing Caregiver Support Implementation through Training and Education) to train cancer centers and their staff in identifying, implementing, evaluating, and sustaining...